Westport Innovations Rallies on Acquisition Chatter and 3 Stock Analyses Making Rounds

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Current Price: $57.18

William Blair has increased the company’s price target due to increased confidence in BMN-701 after the Lysosomal Disease Network WORLD Symposium. The firm still names BioMarin as a top pick for 2013 and reiterates its Outperform rating on stock.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!